Clinical studies found that DNA promoter methylation at some candidate genes, such as tumor necrosis factor (47), estrogen receptor alpha (27), and matrix metalloproteinase-2 (26) were associated with stroke. This evidence concerns the gene MMP2 and stroke disorder.